Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine

BMC Public Health
Manuela TabaliHarald Matthes

Abstract

Recent studies have shown that adverse drug reactions (ADRs) are underreported. This may be particularly true of ADRs associated with complementary and alternative medicine (CAM). Data on CAM-related ADRs, however, are sparse.Objective was to evaluate the impact of an educational intervention and monitoring programme designed to improve physician reporting of ADRs in a primary care setting. A prospective multicentre study with 38 primary care practitioners specialized in CAM was conducted from January 2004 through June 2007. After 21 month all physicians received an educational intervention in terms of face-to-face training to assist them in classifying and reporting ADRs. The study centre monitored the quantity and quality of ADR reports and analysed the results.To measure changes in the ADR reporting rate, the median number of ADR reports and interquartile range (IQR) were calculated before and after the educational intervention. The pre-intervention and post-intervention quality of the reports was assessed in terms of changes in the completeness of data provided for obligatory items. Interrater reliability between the physicians and the study centre was calculated using Cohen's kappa with a 95% confidence interval (CI). We u...Continue Reading

References

Feb 1, 1997·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M CosentinoG Frigo
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Dec 3, 1999·British Journal of Clinical Pharmacology·I A ElandB H Stricker
Apr 12, 2001·Journal of Ethnopharmacology·M Elvin-Lewis
Jun 6, 2002·Journal of Paediatrics and Child Health·G ShenfieldH Allen
Jun 8, 2002·Pharmacoepidemiology and Drug Safety·A C van GrootheestLolkje de Jong-van den Berg
Oct 24, 2002·Journal of Clinical Epidemiology·J HasfordB Müller-Oerlinghausen
Jan 7, 2003·Pharmacoepidemiology and Drug Safety·M BäckströmR Dahlqvist
Jan 10, 2003·Journal of the Royal Society of Medicine·Klaus Linde, Stefan N Willich
Sep 10, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joanne Barnes
Dec 18, 2004·Forschende Komplementärmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine·U Härtel, E Volger
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJuan Jesus Gestal-Otero
Sep 10, 2005·Complementary Therapies in Medicine·Hilary A TindleEllen P McCarthy
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJuan Jesus Gestal-Otero
Sep 7, 2006·JAMA : the Journal of the American Medical Association·Adolfo FigueirasJuan Jesus Gestal-Otero
Sep 13, 2007·Forschende Komplementärmedizin = Research in Complementary Medicine·Elke JeschkeHarald Matthes
Mar 28, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroAdolfo Figueiras
Jul 3, 2008·The Annals of Pharmacotherapy·Chuenjid KongkaewDarren M Ashcroft
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
May 4, 2010·BMC Complementary and Alternative Medicine·Stephen P MyersCarol Morris

Citations

Jul 7, 2012·Therapeutics and Clinical Risk Management·Prerna UpadhyayaMushtaq Ahmed
Feb 9, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·M SüsskindThomas Ostermann
May 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cristian Gonzalez-GonzalezAdolfo Figueiras
Jun 16, 2015·Journal of Educational Evaluation for Health Professions·Muhammad Umair KhanShazia Q Jamshed
May 11, 2011·Journal of the American Pharmacists Association : JAPhA·Paul GavazaMary Steinhardt
Oct 2, 2012·Journal of the American Pharmacists Association : JAPhA·Paul GavazaJames P Wilson
May 6, 2010·Pharmacoepidemiology and Drug Safety
Mar 29, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Megan L SteeleFriedemann Schad
Aug 26, 2014·Healthcare Informatics Research·Noriko NakamuraChiemi Maeda
Apr 6, 2016·Current Medical Research and Opinion·Candace NecykSunita Vohra
Sep 14, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Alma ChavezGulnur Com
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Lisha Jenny JohnJayadevan Sreedharan
Nov 2, 2019·BMJ Open Quality·Jose ValeryFernando F Stancampiano
May 21, 2020·Pharmacoepidemiology and Drug Safety·Malahat KhaliliAli Akbar Haghdoost

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Lorna Hazell, S A W Shakir
© 2021 Meta ULC. All rights reserved